InsidersTradesSigma
Follow the BioNTech SE stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €19.7bn. The latest transaction was filed on 23 April 2026 (Cession). Among the most active insiders: Poetting Sierk. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
BioNTech SE es una empresa biofarmacéutica alemana centrada en el desarrollo de inmunoterapias y vacunas. Es más conocida por su vacuna contra la COVID-19 desarrollada en colaboración con Pfizer.